<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-07T23:34:42Z</responseDate>
  <request identifier="oai:figshare.com:article/33768535" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33768535</identifier>
        <datestamp>2026-09-14T23:42:28Z</datestamp>
        <setSpec>portal_1197</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Data for Photoactivatable cell-selective dinuclear trans-diazidoplatinum(IV) anticancer prodrugs</dc:title>
          <dc:creator>Huayun Shi (3928973)</dc:creator>
          <dc:creator>Isolda Romero-Canelón (8010029)</dc:creator>
          <dc:creator>Monika Hreusova (5900453)</dc:creator>
          <dc:creator>Olga Novakova (11631)</dc:creator>
          <dc:creator>V. Venkatesh (1744150)</dc:creator>
          <dc:creator>Abraha Habtemariam (1338636)</dc:creator>
          <dc:creator>Guy J. Clarkson (1301127)</dc:creator>
          <dc:creator>Ji-Inn Song (4686754)</dc:creator>
          <dc:creator>Viktor Brabec (11634)</dc:creator>
          <dc:creator>Peter J. Sadler (1297341)</dc:creator>
          <dc:subject>Antineoplastic agents -- Development</dc:subject>
          <dc:subject>Platinum compounds -- Therapeutic use</dc:subject>
          <dc:subject>Cisplatin</dc:subject>
          <dc:subject>Azides</dc:subject>
          <dc:subject>Photochemistry</dc:subject>
          <dc:subject>Migrated from ePrints</dc:subject>
          <dc:description>Novel all-trans dinuclear PtIV complexes bridged by a dicarboxylate linker, highly stable in the dark, generate azidyl and hydroxyl radicals upon irradiation with blue light. They are photocytotoxic to human cancer cells, whereas cisplatin was inactive under these conditions and more photoactive toward cisplatin-resistant ovarian cancer cells compared to wild-type cells. Remarkably, the dinuclear complexes were relatively nontoxic toward normal human cells. Cell cycle and DNA binding experiments suggested that DNA is a target.</dc:description>
          <dc:date>2018-01-01T00:00:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.82444/warw.33768535.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Data_for_Photoactivatable_cell-selective_dinuclear_trans-diazidoplatinum_IV_anticancer_prodrugs/33768535</dc:relation>
          <dc:rights>CC BY 3.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
